For many patients, the clinical benefits of GLP-1sparticularly sustained weight loss and metabolic improvementsare closely tied to continued use.[166] Once treatment is discontinued, individuals often experience weight regain and the return of obesity-related health conditions, underscoring the need to view obesity as a chronic condition that may require long-term treatment.[167] Adherence is also influenced by treatment tolerability.[168] While GLP-1s are generally well tolerated, side effects such as gastrointestinal symptoms and the inconvenience of regular self-injections may deter adherence for certain patients.[169] Recognizing the challenges associated with long-term adherence, pharmaceutical companies are innovating through the development of more-convenient delivery methods
One widely repeated analogy frames BPC-157 as the foreman that organises repair at a site and TB-500 as the trucks that move resources to where they are needed
Its always advisable to consult with a healthcare provider before starting any new supplement regimen, especially if you have underlying health conditions
For researchers focused specifically on weight management outcomes, the full escalation to 12mg provides the most robust data, though the 8mg dose produced 22.8% weight loss, only 1.4 percentage points less
Science 359 , 658662 (2018)